文献速递糖尿病

糖尿病与非糖尿病人群肝脏相关死亡率的时间趋势:基于人群研究的结果

Time Trends in Liver-Related Mortality in People With and Without Diabetes: Results From a Population-Based Study.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

该研究利用意大利伦巴第大区医疗数据库,分析2010至2019年糖尿病与非糖尿病人群肝脏相关死因别死亡率趋势。糖尿病人群肝脏病粗死亡率从1.13降至0.64/1000人年,非病毒非酒精性病因占比从63%升至68%,病毒性病因从27%降至23%。糖尿病人群肝脏相关标化死亡比相对稳定,且高于心血管死亡。

要点

  • 2019年肝脏疾病占糖尿病人群死亡的2%,非糖尿病人群为1%。
  • 糖尿病人群肝脏病粗死亡率从2010年1.13降至2019年0.64/1000人年。
  • 非病毒非酒精性肝病标化死亡比3.35(95%CI 2.96-3.76),病毒性肝炎1.66(95%CI 1.33-2.01),酒精性肝病1.61(95%CI 1.13-2.17)。

核心结论

  • 糖尿病人群肝脏相关死亡率在研究期间显著下降,但非病毒非酒精性病因仍占多数。
  • 糖尿病人群肝脏相关超额死亡风险相对于对照人群在研究期间保持恒定。
  • 糖尿病人群肝脏相关超额死亡风险高于心血管死亡和癌症。

研究设计与样本

  • 基于意大利伦巴第大区医疗利用数据库的人群研究,该地区约占意大利人口的16%(近1000万)。
  • 计算2010至2019年糖尿病与非糖尿病人群的年度死因别死亡率和比例死亡率。
  • 肝脏相关死亡分为病毒性、酒精相关和非病毒非酒精相关(NVNA)。

主要发现

  • 2019年肝脏疾病占糖尿病人群死亡的2%,非糖尿病人群为1%。
  • 糖尿病人群肝脏病粗死亡率从2010年1.13降至2019年0.64/1000人年。
  • 肝脏相关死亡中非病毒非酒精性病因占比从2010年63%升至2019年68%,病毒性病因从27%降至23%。
  • 糖尿病人群标化死亡比:非病毒非酒精性3.35(95%CI 2.96-3.76),病毒性肝炎1.66(95%CI 1.33-2.01),酒精性肝病1.61(95%CI 1.13-2.17),随时间相对稳定。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Patients with diabetes are at increased risk of dying from liver-related events, but little is known on whether this increased risk has changed in recent years. OBJECTIVE: The aim of the present study is to describe time trends in cause-specific liver-related mortality in people with and without diabetes from the general Italian population. METHODS: Data were retrieved from the health care utilization databases of Lombardy, a region of Italy that accounts for about 16% (almost 10 million) of its population. Annual cause-specific mortality rates and proportionate mortality were computed among individuals with and without diabetes from 2010 to 2019. Liver-related deaths were categorized as viral, alcohol related, and nonviral nonalcohol related (NVNA). RESULTS: Liver diseases were responsible for 2% and 1% of deaths in people with and without diabetes (2019). Among patients with diabetes, the crude mortality rate for liver diseases decreased from 1.13 to 0.64 deaths per 1000 person-years from 2010 to 2019. The largest proportion of liver-related deaths was attributable to NVNA diseases and it increased from 63% in 2010 to 68% in 2019, with a corresponding relative reduction of viral causes (from 27% to 23%). The standardized mortality ratio for patients with diabetes was 3.35 (95% CI 2.96-3.76) for NVNA, 1.66 (95% CI 1.33-2.01) for viral hepatitis, and 1.61 (95% CI 1.13-2.17) for alcoholic liver disease and it remained relatively stable over time. Excess mortality risk in patients with diabetes for liver-related mortality was higher than for cardiovascular mortality and cancer. CONCLUSION: While liver-related mortality rates decreased significantly among patients with diabetes, NVNA causes made up the majority of cases. Excess mortality for liver-related causes in patients with diabetes compared with controls remained constant in the studied period.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Ciardullo S, Morabito G, Rea F, et al. Time Trends in Liver-Related Mortality in People With and Without Diabetes: Results From a Population-Based Study. J Clin Endocrinol Metab. 2024. PMID: 38506158. doi:10.1210/clinem/dgae182

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。